Eye Diseases: all 747 studies
Page 3 of 8. Open to participants first (118), then studies with results posted, then the rest; newest registration first within each.
- Dry Eye Disease Study With BrimonidineCompletedNCT03418727Phase 2Results posted
- RESCUE and REVERSE Long-term Follow-upCompletedNCT03406104Phase 3Results posted
- Perfluorohexyloctane (NOV03) for the Treatment of Signs and Symptoms of Dry Eye Disease (DED)CompletedNCT03333057Phase 2Results posted
- BCI and Evaluation of Visual and Task Performance in Subjects With Eye DiseasesCompletedNCT03318549Not applicableResults posted
- Treatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical StudyCompletedNCT03298867Phase 3Results posted
- Efficacy & Safety Study of Bilateral IVT Injection of GS010 in LHON Subjects Due to the ND4 Mutation for up to 1 YearCompletedNCT03293524Phase 3Results posted
- CyclASol for the Treatment of Signs and Symptoms of Dry Eye Disease (DED)CompletedNCT03292809Phase 2/3Results posted
- Clinical Efficacy of H.P. Acthar Gel 80 U/ml to Improve the Signs and Symptoms in Subjects With Dry Eye DiseaseCompletedNCT03287635Phase 4Results posted
- Effect of IKERVIS® Eye Drops Once Daily on the Quality of Vision in Dry Eye Disease Patients With Severe KeratitisCompletedNCT03237936Phase 4Results posted
- Glucocorticoids and Bone in Graves' OphthalmopathyCompletedNCT03122847Results posted
- Intense Pulsed Light Study for Dry Eye DiseaseCompletedNCT03089580Not applicableResults posted
- Collagen Cross-Linking With Ultraviolet-A in Asymmetric CorneasTerminatedNCT03029104Phase 2Results posted
- Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye DiseaseCompletedNCT02980224Phase 3Results posted
- Pilot Study for Investigating the Effect of the Bruder Eye Hydrating Compress on Contact Lens Discomfort in Contact Lens WearersCompletedNCT02848222Not applicableResults posted
- Celecoxib for Thyroid Eye DiseaseTerminatedNCT02845336Phase 2Results posted
- Evaluation of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye DiseaseTerminatedNCT02831387Phase 2Results posted
- Study of the Pharmacodynamic Activity of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye DiseaseTerminatedNCT02824913Phase 2Results posted
- Feasibility Study of Retinal Screening Using the RetinaVue 100 Camera in Outpatient Dialysis CentersCompletedNCT02823600Not applicableResults posted
- Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye DiseaseCompletedNCT02819284Phase 3Results posted
- Safety and Efficacy of KPI-121 in Subjects With Dry Eye DiseaseCompletedNCT02813265Phase 3Results posted
- Efficacy Study of GS010 for Treatment of Vision Loss From 7 Months to 1 Year From Onset in LHON Due to the ND4 Mutation (REVERSE)CompletedNCT02652780Phase 3Results posted
- Efficacy Study of GS010 for the Treatment of Vision Loss up to 6 Months From Onset in LHON Due to the ND4 MutationCompletedNCT02652767Phase 3Results posted
- CyclASol for the Treatment of Moderate to Severe Dry-eye Disease (DED)CompletedNCT02617667Phase 2Results posted
- Evaluation of Oral Minocycline in the Treatment of Geographic Atrophy Associated With Age-Related Macular DegenerationCompletedNCT02564978Phase 2Results posted
- A Safety and Efficacy Study of a New Eye Drop Formulation in Patients With Dry Eye Disease.CompletedNCT02553772Phase 3Results posted
- Rituximab (RTX) Therapy in Patients With Active TAOCompletedNCT02378298Phase 4Results posted
- LME636 in the Relief of Persistent Ocular Discomfort in Subjects With Severe Dry Eye DiseaseCompletedNCT02365519Phase 2Results posted
- X-82 to Treat Age-related Macular DegenerationTerminatedNCT02348359Phase 2Results posted
- A Study to Evaluate Efficacy and Safety of Lifitegrast in Subjects With Dry Eye (OPUS-3)CompletedNCT02284516Phase 3Results posted
- Phase 2/3 Dose-Ranging Study of the Safety and Efficacy of OTX-101 in the Treatment of Keratoconjunctivitis SiccaCompletedNCT02254265Phase 2/3Results posted
- Prevalence of Dry Eye Disease in Patients Diagnosed With Rheumatoid ArthritisCompletedNCT02252744Results posted
- Safety and Efficacy of KPI-121 in Subjects With Dry Eye DiseaseCompletedNCT02188160Phase 2Results posted
- Aflibercept After Ranibizumab in Exudative Age-related Macular DegenerationCompletedNCT02157077Phase 3Results posted
- The Utility of IVCM to Assess Cellular Response and Efficacy of Long-term Topical Steroid Treatment in Patients With DEDCompletedNCT02120079Phase 4Results posted
- Phase 2 Study of a New Ophthalmic Formulation of Cyclosporine (Restasis® X) in Patients With Dry Eye DiseaseTerminatedNCT02013791Phase 2Results posted
- Teprotumumab (RV 001) Treatment in Patients With Active Thyroid Eye DiseaseCompletedNCT01868997Phase 2Results posted
- Lotemax® Gel 0.5% and Restasis 0.05% in Participants With Mild or Moderate Keratoconjunctivitis Sicca (Dry Eye Disease)CompletedNCT01817582Phase 2Results posted
- Twenty-four Hour Intraocular Pressure Patterns in Patients With Uncontrolled Thyroid Eye DiseaseCompletedNCT01798966Not applicableResults posted
- A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry EyeCompletedNCT01743729Phase 3Results posted
- A Study to Compare the Safety and Efficacy of A New Eye Drop Formulation With OPTIVE™ in Subjects With Dry Eye DiseaseCompletedNCT01664949Phase 3Results posted
- Evaluation of Ocular Comfort With ISTA Tears vs SystaneCompletedNCT01650584Not applicableResults posted
- CNTF Implants for CNGB3 AchromatopsiaCompletedNCT01648452Phase 1/2Results posted
- Safety Study of Lifitegrast to Treat Dry EyeCompletedNCT01636206Phase 3Results posted
- Safety and Efficacy Study of SAR 1118 to Treat Dry Eye Conducted in a Controlled Adverse Environment (CAE) (OPUS-1)CompletedNCT01421498Phase 3Results posted
- Evaluation of Anti-Inflammatory Treatment in Dry Eye PatientsCompletedNCT01276223Phase 2Results posted
- Trial of CF101 to Treat Patients With Dry Eye DiseaseCompletedNCT01235234Phase 3Results posted
- Study of 2.0 mg Ranibizumab in Subjects With Ischemic Central Retinal Vein Occlusion (RAVE2)TerminatedNCT01225146Phase 1Results posted
- A Phase II, Dose Ranging Study Of CP-690,550 Eye Drops In Patients With Dry Eye DiseaseCompletedNCT01135511Phase 2Results posted
- A Safety and Tolerability Study of Otelixizumab in Thyroid Eye DiseaseTerminatedNCT01114503Phase 2Results posted
- Pilot Study of a Homeopathic Therapy in Combination With Cyclosporin (Restasis) in the Treatment of Dry Eye DiseaseTerminatedNCT01072526Phase 2Results posted
- INTREPID - IRay Plus Anti-VEGF Treatment For Patients With Wet AMDCompletedNCT01016873Phase 2Results posted
- Safety And Tolerability Study Of RN6G In Subjects With Advanced Dry, Age-Related Macular Degeneration Including Geographic AtrophyCompletedNCT01003691Phase 1Results posted
- Safety And Tolerability Study Of RN6G In Patients With Dry, Age-Related Macular DegenerationCompletedNCT00877032Phase 1Results posted
- TearLab Core Validation Study to Establish Referent Values for Dry Eye DiseaseCompletedNCT00848198Results posted
- Physician's Evaluation of Cyclosporine Ophthalmic Emulsion 0.05%CompletedNCT00827255Results posted
- Safety and Efficacy of an Ophthalmic Solution in Dry Eye DiseaseCompletedNCT00758784Phase 2Results posted
- Efficacy Study of Ecabet Ophthalmic Solution in Dry Eye DiseaseCompletedNCT00667004Phase 2Results posted
- Tear Film Stability After Instillation of Over-the-Counter (OTC) Artificial DropsCompletedNCT00610480Not applicableResults posted
- Trial of Rituximab for Graves' OphthalmopathyCompletedNCT00595335Phase 2/3Results posted
- Age-Related Eye Disease Study 2 (AREDS2)CompletedNCT00345176Phase 3Results posted
- Ralation Between Cardiorespiratory Fitness and Mean Corrected Intraocular PressureCompletedNCT07676747
- Effect of Nutritional Supplement Alpha-ketoglutarate for Age-related Ocular DiseaseCompletedNCT07269704Early Phase 1
- Ophthalmic Diseases and AI: an RCT StudyCompletedNCT07154680
- Dry Eye Disease and Retinal Nerve Fiber Layer Thickness in Chronic SmokersCompletedNCT07028736
- Once-daily Fluorometholone vs Twice-daily Cyclosporine in Dry Eye DiseaseCompletedNCT06876116Phase 4
- Exploratory Study on the Effectiveness of Myopia Control Lenses in Slowing Myopia Progression in Young ChildrenActive, not recruitingNCT06857864Not applicable
- Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-Related Macular DegenerationActive, not recruitingNCT06856577Phase 3
- The Effect of 0.05% CsA Eye Drops on Diabetic Patients with Dry Eye DiseaseCompletedNCT06824844Phase 4
- Efficacy of Pilocarpine As a Secretagogue Versus Artificial Tears for the Treatment of Dry EyeCompletedNCT06752278Not applicable
- The Effect of Omega 3 Supplements Comparison With Warm Compression in Patients With Dry Eye DiseaseActive, not recruitingNCT06748768
- Treatment Effect of Intense Pulsed Light and Thermal Pulsation Therapy on Meibomian Gland Dysfunction-associated Dry Eye Disease: a Randomized TrialCompletedNCT06745089Not applicable
- Hydroxypropyl-methylcellulose and GlicoPro® Eyedrops in the Treatment of Dry Eye Disease: Clinical StudyCompletedNCT06726525Phase 4
- An Observational Study to Evaluate the ETX-4143 Device in Subjects With Ocular HypertensionWithdrawnNCT06709300
- Laser Acupuncture for Dry Eye Disease Due to Visual Display Terminal UseCompletedNCT06688630Not applicable
- A Real-World Evidence Study of Goniotomy With the C-REX™ Instrument in Patients With Primary Open Angle GlaucomaActive, not recruitingNCT06615661
- Cross-linked CMC and Silk Proteins in Eye DiseaseCompletedNCT06605365
- Efficacy of Twinkle Eyez Supplementation in Improving Ocular Health and ImmunityCompletedNCT06574685Not applicable
- Ophthalmic Solution in Diabetic Corneal AlterationCompletedNCT06573606
- A Study to Evaluate Corneal Endothelial Cell Density (ECD) in Subjects With Dry Eye Disease (DED) Administering Miebo® (Perfluorohexyloctane Ophthalmic Solution) for 12 Months.Active, not recruitingNCT06565650Phase 4
- Evaluation of Reflex Tear ProductionTerminatedNCT06565624Not applicable
- Ditefossol Sodium 3% Eye Drops in Patients With Dry EyeCompletedNCT06560580Not applicable
- Efficacy and Safety of a Multiple-Action Tear Substitute (TriMix) in Dry Eye DiseaseCompletedNCT06478134Phase 2/3
- MAD of IVT VP-001 in PRPF31 Mutation-Associated Retinal Dystrophy Subjects (Wallaby)CompletedNCT06455826Phase 1
- Comparing Efficacy and Safety of TJO-083 in Dry Eye Diseases PatientsCompletedNCT06427031Phase 3
- A Study to Evaluate the Efficacy and Safety of Tanfanercept (HL036) in Dry Eye DiseaseSuspendedNCT06400589Phase 3
- Effect of Periorbital Massage on Dry Eye DiseaseActive, not recruitingNCT06390644Not applicable
- A Study of TEPEZZA® Treatment in Participants With Thyroid Eye DiseaseCompletedNCT06389578Phase 1
- A Clinical Trial to Assess the Efficacy and Safety of Subjects With Dry Eye DiseaseCompletedNCT06389214Phase 3
- Clinical Study to Evaluate the Safety and Tolerability of PRO-229 Ophthalmic Solution Compared to Lagricel® Ofteno PFCompletedNCT06370585Phase 1
- Tocilizumab in Corticosteroid-Resistant Graves' Orbitopathy (Thyroid Eye Disease)CompletedNCT06367517
- Prospective Evaluation of Efficacy and Safety of an Intense Pulsed Light Device to Treat Dry Eye Disease"CompletedNCT06349356Not applicable
- A Phase 3 Study to Evaluate AZR-MD-001 in Patients with Abnormal Meibomian Gland Function and Dry Eye Disease (DED)Active, not recruitingNCT06329791Phase 3
- Natural History Study in Patients With PDE6A-, PDE6B- and RHO-linked Retinitis PigmentosaActive, not recruitingNCT06323772
- Vizol S Lipid Balance Efficacy and Safety Study in Patients With Dry EyeCompletedNCT06323395Phase 3
- Ocular Trauma and COVID-19 in IndonesiaCompletedNCT06291844
- Safety and Efficacy Study of IVB102 Injection in Subjects With X-linked RetinoschisisActive, not recruitingNCT06289452Early Phase 1
- A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer Compared With Sham Treatment in Participants With Diabetic Retinopathy (DR)CompletedNCT06270836Phase 3
- Collection of Ocular Surface Impressions Cytology of the Living Eye From Patients With Dry Eyes or Limbal Stem Cell Deficiency.CompletedNCT06255301
- Clinical Study Using Eye Lipid Mobilizer (ELM) With Heat and Vibration To Treat Evaporative Dry Eye DiseaseCompletedNCT06242860Not applicable
- A Study of TL-925 Ophthalmic Emulsion as a Treatment for Dry Eye DiseaseActive, not recruitingNCT06225973Phase 2